Induced pluripotent stem cells and their use in human models of disease and development

P Karagiannis, K Takahashi, M Saito… - Physiological …, 2019 - journals.physiology.org
The discovery of somatic cell nuclear transfer proved that somatic cells can carry the same
genetic code as the zygote, and that activating parts of this code are sufficient to reprogram …

Human induced pluripotent stem cell–derived cardiomyocytes: insights into molecular, cellular, and functional phenotypes

I Karakikes, M Ameen, V Termglinchan… - Circulation research, 2015 - Am Heart Assoc
Disease models are essential for understanding cardiovascular disease pathogenesis and
develo** new therapeutics. The human induced pluripotent stem cell (iPSC) technology …

Induced pluripotent stem cells 10 years later: for cardiac applications

Y Yoshida, S Yamanaka - Circulation research, 2017 - Am Heart Assoc
Induced pluripotent stem cells (iPSCs) are reprogrammed cells that have features similar to
embryonic stem cells, such as the capacity of self-renewal and differentiation into many …

[HTML][HTML] Cardiomyocytes from human pluripotent stem cells: from laboratory curiosity to industrial biomedical platform

C Denning, V Borgdorff, J Crutchley, KSA Firth… - … et Biophysica Acta (BBA …, 2016 - Elsevier
Cardiomyocytes from human pluripotent stem cells (hPSCs-CMs) could revolutionise
biomedicine. Global burden of heart failure will soon reach USD $90 bn, while unexpected …

Translation of human-induced pluripotent stem cells: from clinical trial in a dish to precision medicine

N Sayed, C Liu, JC Wu - Journal of the American College of Cardiology, 2016 - jacc.org
The prospect of changing the plasticity of terminally differentiated cells toward pluripotency
has completely altered the outlook for biomedical research. Human-induced pluripotent …

Induced pluripotent stem cells: the new patient?

M Bellin, MC Marchetto, FH Gage… - Nature reviews Molecular …, 2012 - nature.com
Worldwide increases in life expectancy have been paralleled by a greater prevalence of
chronic and age-associated disorders, particularly of the cardiovascular, neural and …

Induced pluripotent stem cells for cardiovascular disease modeling and precision medicine: a scientific statement from the American Heart Association

K Musunuru, F Sheikh, RM Gupta… - Circulation: Genomic …, 2018 - Am Heart Assoc
Induced pluripotent stem cells (iPSCs) offer an unprece-dented opportunity to study human
physiology and disease at the cellular level. They also have the potential to be leveraged in …

Investigating human disease using stem cell models

JL Sterneckert, P Reinhardt, HR Schöler - Nature Reviews Genetics, 2014 - nature.com
Tractable and accurate disease models are essential for understanding disease
pathogenesis and for develo** new therapeutics. As stem cells are capable of self …

Induced pluripotent stem cells: at the heart of cardiovascular precision medicine

IY Chen, E Matsa, JC Wu - Nature Reviews Cardiology, 2016 - nature.com
The advent of human induced pluripotent stem cell (hiPSC) technology has revitalized the
efforts in the past decade to realize more fully the potential of human embryonic stem cells …

Recessive cardiac phenotypes in induced pluripotent stem cell models of Jervell and Lange-Nielsen syndrome: disease mechanisms and pharmacological rescue

M Zhang, C D'Aniello, AO Verkerk… - Proceedings of the …, 2014 - National Acad Sciences
Jervell and Lange-Nielsen syndrome (JLNS) is one of the most severe life-threatening
cardiac arrhythmias. Patients display delayed cardiac repolarization, associated high risk of …